COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.[1] By 15 July 2020, 165 countries – representing 60% of the human population – had joined COVAX.[2] However, as of 11 April 2021, COVAX is falling short of its goal, having delivered 38.5 million doses despite a goal of 100 million by the end of March.[3][4]